XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona announces a comprehensive restage of its Implant business

Dentsply Sirona announces a comprehensive restage of its Implant business

  • With a digital base, historical product strength and signature workflows supported by ongoing education and training, Dentsply Sirona is launching DS Implants, harmonizing successful brands like Simplant, OSSIX, Atlantis and MIS.

  • Three completely connected, seamless signature workflows will take full advantage of digital dentistry for excellent outcomes and patient satisfaction.
  • DS Implants presents DS PrimeTaper, a self-tapping implant with a tapered design that can be inserted safely and easily with a unique double thread, enabling long-term bone stability.

CHARLOTTE, N.C., Sept. 23, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY) introduces a comprehensive restage of its Implants business, including three signature workflows to provide dental professionals with a completely new way of practicing implantology and solutions from scan to crown that outperform expectations in efficiency, accuracy, esthetics, longevity and simplicity.

  • The Single Tooth Signature Workflow enables customers to do more and better, faster, simpler, freeing up time to see more patients.
  • The Partial Multiple Tooth Replacement Signature Workflow for more confidence for the clinician and more comfort for the patient.
  • The Full Arch Signature Workflow addresses a signature patient case with an edentulous maxilla.

With a complete ecoystem of digital solutions and products Dentsply Sirona is streamlining implant treatments for practice growth and consistent patient satisfaction. 

Comfort with new products based on well-known procedures

Additionally, Dentsply Sirona Implants presents DS PrimeTaper, a self-tapping implant with a tapered design that can be inserted safely and easily with a unique double thread, enabling long-term bone stability. Dentsply Sirona worked closely with the global implant key opinion leader community, and they have already started gaining experience with the product. Their reactions have been very positive:

Dr. Dan Butterman, dentist from Centennial, Colorado (USA), emphasizes the importance of a seamless workflow. “DS PrimeTaper represents the next step in implant dentistry. The digital-driven workflow results in higher accuracy, repeatability of processes, and time savings.” Butterman adds, "My patients have better things to do than spending time in my office. Thanks to clearly defined processes and digital solutions, I can offer safer and faster treatment options which my patients appreciate. That's what efficiency is all about!"

Seamless concept for transforming digital implant dentistry

“Dentsply Sirona is about intelligent concepts that work intuitively and improve the predictability of treatment,” said Dr. Terri Dolan, Chief Clinical Officer at Dentsply Sirona. “Our goal is to enable clinicians, including both specialists and general practitioners, to focus on what they do best – creating healthy and beautiful smiles. Our vision for digital implant dentistry will be supported by a global clinical education program focused on end-to-end digital implant workflow solutions to achieve clinic, technical and practice excellence. The extensive curriculum is designed to build clinicians’ digital implant skills according to their level of experience and personal learning preferences. These include online education and personalized learning, as well as more than 50 state-of-the art Dentsply Sirona Academy education centers around the world.”

About Dentsply Sirona

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 134-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company, Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry. The Company’s shares of common stock are listed in the United States on Nasdaq under the symbol XRAY. Visit for more information about Dentsply Sirona and its products.

Contact Information

Investors:

Andrea Daley

VP, Investor Relations





EN
24/09/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DENTSPLY SIRONA Inc.

Dentsply Sirona Inc: 2 directors

Two Directors at Dentsply Sirona Inc bought/maiden bought 55,000 shares at between 13.469USD and 14.148USD. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company'...

 PRESS RELEASE

Dentsply Sirona to Participate in the Leerink Partners Global Healthca...

Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2026 CHARLOTTE, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Leerink Partners Global Healthcare Conference. Management is scheduled to present on Tuesday, March 10, 2026, at 10:00 a.m. EST. Investors and other interested parties will be able to access a live audio webcast and an audio webcast replay by visiting the Investors section of the Dentsply Sirona website at About Dentspl...

 PRESS RELEASE

Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Pro...

Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook News Summary Q4 2025 net sales of $961 million increased 6.2%, constant currency sales increased 2.5%Q4 2025 reported net loss of ($146) million and diluted loss per share of ($0.74) driven by goodwill and intangible impairments of ($144) million, net of taxQ4 2025 adjusted EPS of $0.27FY 2026 outlook: net sales in the range of $3.5B to $3.6B; adjusted EPS of $1.40 to $1.50(1)Announced a restructuring initiative to redirect approximately $120 million annually into the Return-to-Growth Action ...

 PRESS RELEASE

Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Dir...

Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors New directors bring decades of financial leadership and board experience to enhance strategic oversight of Return-to-Growth action plan and long-term value creation CHARLOTTE, N.C., Feb. 24, 2026 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced the appointments of James (Jim) D. Forbes and Brian P. McKeon to its Board of Directors (the “Board”), effective February 27, 2026. Mr. Forbes is a veteran healthcare investment banker with 30 years of experie...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch